Growth factors and their peptide mimetics for treatment of traumatic brain injury ScienceDirect DIHEXA PEPTIDE 10MG VIAL UMBRELLA Labs The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Efficacy and Safety of Cagrilintide Alone and in : Indian Journal of Endocrinology and Metabolism